Colorectal cancer Posts on Medivizor
Navigation Menu

Colorectal cancer Posts on Medivizor

High dose vitamin D supplementation may be associated with improved colorectal cancer outcomes

Posted by on May 19, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated if high-dose vitamin D combined with chemotherapy improves outcomes in patients with metastatic (spread to other parts of the body) colorectal cancer. Researchers suggested that high-dose vitamin D was associated with an improved chance of survival. Some background Vitamin D is associated with the intake of...

Read More

Circulating Tumor DNA Detecting Colorectal Cancer Recurrences Early

Circulating Tumor DNA Detecting Colorectal Cancer Recurrences Early

Posted by on May 18, 2019 in Blog, Colorectal cancer | 0 comments

A recent article in the Journal of the American Medical Association-Oncology (JAMA) contains an exciting strategy (made possible again by all the work of the Human Genome Project) for treatment decision making and finding recurrences earlier for those diagnosed with colorectal cancer. Colorectal cancer is the third most common cancer. Treatment involves...

Read More

Stereotactic body radiotherapy improves treatment response in metastatic colorectal cancer

Posted by on May 16, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of stereotactic body radiotherapy (SBRT) in metastatic (spread to other parts of the body) colorectal cancer. Researchers suggested that SBRT is associated with improved tumor response and manageable side effects. Some background Colorectal cancer is the second most commonly diagnosed cancer in...

Read More

Recommendations to improve the quality of life of colorectal cancer survivors

Posted by on Apr 25, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines in the health-related quality of life of patients who survived colorectal cancer. Researchers suggested that following these guidelines might be associated with improved health. Some background In 2007 the...

Read More

Cold Tumors?

Cold Tumors?

Posted by on Apr 21, 2019 in Blog, Breast cancer, Colorectal cancer, Prostate cancer | 1 comment

New: Thanks to InVideo, we have a video version of the post below. Check it out at bottom of the post. Incredible immunotherapy responses in some cancers, but not in others, have puzzled the research community. What is it about some cancers that allows the immune system to be activated? Why are some cancers able to evade the immune system even when...

Read More

Long-short radiation therapy before surgery is associated with better outcomes in stage 2 and 3 rectal cancer

Posted by on Apr 21, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared the survival outcomes of patients with rectal cancer who underwent short- or long-course radiation therapy (RT). Researchers suggested that long-course RT was associated with greater tumor response and survival. Some background Colorectal cancer is the third most common cancer diagnosed in the United States. The...

Read More

Are colorectal cancer survivors at risk of hormonal and metabolic disease?

Posted by on Apr 19, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the short- and long-term occurrence of hormonal and metabolic disorders in colorectal cancer survivors. Researchers suggested that the occurrence of these types of disorders was higher in these patients. Some background Colorectal cancer is the third most common cancer in the United States. With current...

Read More

Enhanced recovery pathways improve outcomes for patients with rectal cancer

Posted by on Apr 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of patients with rectal cancer who received enhanced recovery pathway (ERP) in combination with surgery. Researchers suggested that ERP was associated with longer overall survival. Some background The standard treatment for rectal cancer is surgery, chemotherapy and radiation therapy. However, rectal...

Read More

New treatment improves tumor response in patients with HER2 positive metastatic colorectal cancer

Posted by on Apr 8, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of pertuzumab (Perjeta) and trastuzumab (Herceptin) in patients with colorectal cancer and HER2 mutation (an abnormal gene). Researchers suggested that this treatment could be a safe option for patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Some background...

Read More

FOLFIRI plus aflibercept in the treatment of metastatic colorectal cancer outside of clinical trials

Posted by on Mar 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the combined treatment FOLFIRI with aflibercept (Zaltrap) outside of clinical trials in patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that this treatment might be a safe second line option in patients who progressed after first-line...

Read More

Consolidation chemotherapy before surgery improves the outcomes in advanced rectal cancer.

Posted by on Mar 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of consolidation chemotherapy after initial treatment in locally advanced rectal cancer. Researchers suggested that this treatment is safe and is associated with improved cancer outcomes.  Some background Colorectal cancer is the fifth most common cancer. From all the colorectal...

Read More